FMP
XOMA Corporation
XOMA
NASDAQ
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
19.81 USD
0.03 (0.151%)
Balance Sheet
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Total Cash
84.22M
94.1M
58.16M
153.45M
105.18M
30.24M
32.1M
34.07M
36.17M
38.39M
Total Cash %
286.62
246.6
965.01
3.23k
369.23
100
100
100
100
Receivables
1.79M
209k
2.37M
15.22M
17.02M
12.44M
13.2M
14.01M
14.88M
15.79M
Receivables %
6.09
0.55
39.27
319.86
59.73
41.13
41.13
41.13
41.13
Inventories
1.61M
2.05M
1
-
-
656.3k
696.67k
739.51k
784.99k
833.27k
Inventories %
5.48
5.37
0
-
-
2.17
2.17
2.17
2.17
Payable
456k
1.07M
524k
653k
1.05M
1.84M
1.96M
2.08M
2.2M
2.34M
Payable %
1.55
2.81
8.69
13.72
3.7
6.1
6.1
6.1
6.1
Cap Ex
-1.21M
-26.5M
-23.25M
-17k
-20k
-10.52M
-11.17M
-11.86M
-12.59M
-13.36M
Cap Ex %
-4.11
-69.44
-385.71
-0.36
-0.07
-34.8
-34.8
-34.8
-34.8
